Objectives The acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis
is one of the main causes of high mortality in patients with COVID-19 (novel coronavirus …

Defining the duration of infectivity of Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has major implications for public health and infection control practice in …

Background Since the start of the COVID‐19 pandemic, there have been many scientific
reports regarding gastrointestinal manifestations. Several reports indicate the possibility of …

Recent studies have demonstrated immunologic dysfunction in severely ill coronavirus
disease 2019 (COVID-19) patients. We use single-cell RNA sequencing (scRNA-seq) to …

The pandemic coronavirus disease 19 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been spread rapidly worldwide with …

Background To systematically review the literature about the association between systemic
corticosteroid therapy (CST) and outcomes of COVID-19 patients. Methods We searched …

Determining SARS-CoV-2 viral infectivity is crucial for patient clinical assessment and
isolation decisions. We assessed subgenomic RNA (sgRNA) as a surrogate marker of SARS …

Objective: To evaluate determinants of prolonged viral RNA shedding in hospitalized
patients with SARS-CoV-2 infection. Materials and methods: Hospitalized patients with …

We examined the pathogenicity of severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) in cynomolgus macaques for 28 days to establish an animal model of COVID-19 for …

Background Evidence of glucocorticoids on viral clearance delay of COVID-19 patients is
not clear. Methods In this systematic review and meta-analysis, we searched for studies on …